Article
Generally speaking, for Stage 2 of meaningful use, the bar has been raised; the threshold for measures is higher than it was in Stage 1.
Study to evaluate impact of ArteraAI on clinical decision-making for prostate cancer
Pearls & Perspectives: Understanding and Improving Pelvic Health, with Diane Newman, DNP
Ultrasound imaging system now available to guide nonsurgical urology procedures
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance
CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC